Gossamer Bio (GOSS) Tmuɣli n wazal
Ṛṛbem n lḥedd$11.28Yettwalemmaḍ 21 Sep 2026 19:59 UTC
Beddel+5.13%
Asnulfu n AI: GOSS
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Gossamer Bio, Inc. is a biopharmaceutical company engaged in the discovery, acquisition, and development of therapeutic agents in areas such as immunology, inflammation, and oncology. Gossamer Bio serves customers in the United States.
